[1]
2013. A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations. Farmeconomia. Health Economics and Therapeutic Pathways. 14, 4 (Dec. 2013), 153–160. DOI:https://doi.org/10.7175/fe.v14i4.886.